eBioMedicine in conversation with
Editors at eBioMedicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to this open access journal, this podcast covers a broad range of topics, from climate change and health to microplastics in human tissues, the microbiome-gut-brain axis and binge drinking to computational pathology in 2030, and more.
Listen on:
Episodes

Feb 18, 2022
Feb 18, 2022
14 min
Professor Marc Mansour and Dr Victor Llombart join eBioMedicine to discuss the “undruggable” MYC in cancer. Continue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Jan 18, 2022
Jan 18, 2022
16 min
Rachel Deer joins eBioMedicine to present a study encouraging characterization of long COVID symptoms via human phenotype ontology.Read the full article:Characterizing Long COVID: Deep Phenotype of a Complex ConditionContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Dec 22, 2021
Dec 22, 2021
14 min
James Zou & David Ouyang join eBioMedicine to discuss issues around deep learning and hidden clinical correlates.Continue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Dec 14, 2021
Dec 14, 2021
22 min
Prof Beate Kampmann, Dr Karen Keddy, and Prof Peter Ghazal discuss a new cross-journal Series in The Lancet Infectious Diseases and eBioMedicine addressing the potential for and challenge of applying big data to childhood infectious diseases in LMICs.Read the full Series:https://www.thelancet.com/series/big-data-childhood-infections-LMICs Continue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Nov 16, 2021
Nov 16, 2021
17 min
Dr Anthony Chirwa and Dr Ben Morton join eBioMedicine to discuss controlled infections in Streptococcus Pneumoniae and the importance of localised research.Read the full article:https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(21)00372-8/fulltextContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Oct 27, 2021
Oct 27, 2021
16 min
Jodi Sherman joins Julie Stacey and Liam Messin of eBioMedicine to discuss the intersection between healthcare and climate change.Continue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Sep 22, 2021
Sep 22, 2021
13 min
How can we ensure that research being conducted is relevant to its ultimate end-users? Grace Fox and Dr Manoj Lalu join eBioMedicine to discuss the importance of patient engagement in preclinical research.Further reading:Patient engagement in preclinical laboratory research: A scoping reviewContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Aug 4, 2021
Aug 4, 2021
9 min
Dr Aleix Prat on the relationship between chemotherapy effectiveness and menopause in patients with breast cancer.Further reading:https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(21)00244-9/fulltextContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Jun 29, 2021
Jun 29, 2021
14 min
Dr. Viviana Simon and Dr. Maria Rescigno discuss their proposal that people who have recovered from symptomatic COVID-19 may require only one dose of an mRNA vaccine.Further reading:https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(21)00194-8/fulltextContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
